These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34278510)

  • 1. [Retracted] Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells.
    Yang Q; Zhang S; Kang M; Dong R; Zhao J
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
    Qu Y; Xia P; Zhang S; Pan S; Zhao J
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34726252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retracted] Synthetic miR‑145 mimic inhibits multiple myeloma cell growth
    Zhang Q; Yan W; Bai Y; Xu H; Fu C; Zheng W; Zhu Y; Ma J
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor.
    Pang X; Huang K; Zhang Q; Zhang Y; Niu J
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retracted] MicroRNA‑128 suppresses cell growth and metastasis in colorectal carcinoma by targeting IRS1.
    Wu L; Shi B; Huang K; Fan G
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retracted] miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma.
    Liu K; Liu S; Zhang W; Ji B; Wang Y; Liu Y
    Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34726253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retracted] MicroRNA‑154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.
    Zhou H; Zhang M; Yuan H; Zheng W; Meng C; Zhao D
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retracted] MiR‑132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3.
    Liu K; Li X; Cao Y; Ge Y; Wang J; Shi B
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retracted] miR‑338‑3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2.
    Wen C; Liu X; Ma H; Zhang W; Li H
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retracted] Synergistic effects of eukaryotic co‑expression plasmid‑based STAT3‑specific siRNA and LKB1 on ovarian cancer
    Pan Y; Zhang L; Zhang X; Liu R
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34296300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin.
    Tian H; Hou L; Xiong YM; Huang JX; She YJ; Bi XB; Song XR
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35039879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retracted] miR‑494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
    Liu K; Liu S; Zhang W; Jia B; Tan L; Jin Z; Liu Y
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34850964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma
    Liu J; Dong BF; Wang PS; Ren PY; Xue S; Zhang XN; Han Z; Chen G
    Oncol Rep; 2022 May; 47(5):. PubMed ID: 35234269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retracted] miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
    Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retracted] MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
    Zhang C; Long F; Wan J; Hu Y; He H
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retracted] Knockdown of AQP1 inhibits growth and invasion of human ovarian cancer cells.
    Wang Y; Fan Y; Zheng C; Zhang X
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34676877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retracted] Function of miR‑212 as a tumor suppressor in thyroid cancer by targeting SIRT1.
    Li D; Bai L; Wang T; Xie Q; Chen M; Fu Y; Wen Q
    Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34435654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retracted] miR‑137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.
    Dong S; Jin M; Li Y; Ren P; Liu J
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34318908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retracted] MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling.
    Zhang C; Hu Y; Wan J; He H
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retracted] miR‑133a inhibits cervical cancer growth by targeting EGFR.
    Song X; Shi B; Huang K; Zhang W
    Oncol Rep; 2021 Jul; 46(2):. PubMed ID: 34080664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.